Orasure Tech Inc (OSUR)

$4.46 +0.05 (1.13%)
Market Cap 307.07M
Revenue (ttm) 115.02M
Net Income (ttm) -68.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -59.75%
Debt to Equity Ratio 0.00
Volume 871,000
Avg Vol 694,992
Day's Range N/A - N/A
Shares Out 68.85M
Stochastic %K 79%
Beta 1.02
Analysts Hold
Price Target $3.50

Company Profile

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVI...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 610 882 1820
Address:
220 East First Street, Bethlehem, United States
Ageslow
Ageslow Jun. 24 at 10:20 PM
$OSUR could get Sherlock approval soon, it opens the door to a $1.5B STI testing market with the first true one-of-a-kind disposable molecular self-test — 30-min results from a swab, far faster and more user-friendly than today’s lab PCR tests. Estimated price per test: $6–15 vs lab equivalents $50–100+. This could be worth multiples of current revenue. Share price could increase 2–5x in not to distant future.
0 · Reply
DARKP00L
DARKP00L Jun. 11 at 12:16 PM
$OSUR 08:07 on Jun. 11 2026 OraSure Technologies Subsidiary DNA Genotek Receives FDA Clearance For Urine Collection Kits Use In Roche's STD Screening Kits #tradeideas
0 · Reply
MBSB
MBSB May. 28 at 6:11 PM
$OSUR i wonder if US will puchase tests for the upcoming World Cup…
0 · Reply
Estimize
Estimize May. 27 at 1:03 PM
Wall St is expecting -0.18 EPS for $OSUR Q2 [Reporting 08/11 AMC] http://www.estimize.com/intro/osur?chart=historical&metric_name=eps&utm_c
0 · Reply
Bill614
Bill614 May. 26 at 10:51 PM
$OSUR Could this be the reason Orasure has spiked over the last two trading sessions? “The OraQuick Ebola Rapid Antigen Test by OraSure Technologies is the first FDA-cleared rapid diagnostic test for Ebola. It provides presumptive detection of Ebola virus antigens in about 4-30 minutes and is used exclusively for symptomatic individuals or to screen recently deceased individuals.”
0 · Reply
insanitywolftrading
insanitywolftrading May. 21 at 10:46 PM
$OSUR $CODX both have done well but the PPE stocks are virgin territory that have not seen a major flow of volume into them yet, just trailblazers
0 · Reply
TI7812
TI7812 May. 21 at 3:03 PM
$OSUR got idea from @Hkuppy free KEDM sub. LLM AI - i forgot which one I used. lol. GROK GEMINI CLAUDE, I just don't remember. but it does look like Gemini's style. Especially like the cash per share from a R/R. GTLA
1 · Reply
deepthinker
deepthinker May. 15 at 5:04 PM
$OSUR They’ll be down to about $90 million at end of 2027. So, they’ll have spent $200 million for not much in terms of revenue growth. I can see why activists might be frustrated.
0 · Reply
RunnerSignals
RunnerSignals May. 8 at 1:29 PM
$OSUR vol 4.1x on a +4.33% move. RSI 56, room to 70. Above MA50 and MA200. MACD confirmed same session
1 · Reply
focafoca99
focafoca99 May. 6 at 8:40 PM
$OSUR released its quarter ended March 31, 2026 financial results and held a webcast.
0 · Reply
Latest News on OSUR
OraSure announces FDA clearance of Colli-Pee Dx Urine Collection Kit

2026-06-11T12:34:16.000Z - 18 days ago

OraSure announces FDA clearance of Colli-Pee Dx Urine Collection Kit

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections

Jun 11, 2026, 8:00 AM EDT - 18 days ago

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections

OraSure Technologies Earnings Call Transcript: Q1 2026

May 6, 2026, 5:00 PM EDT - 7 weeks ago

OraSure Technologies Earnings Call Transcript: Q1 2026

OraSure Technologies Earnings release: Q1 2026

May 6, 2026, 5:00 PM EDT - 7 weeks ago

OraSure Technologies Earnings release: Q1 2026

OraSure Technologies Quarterly report: Q1 2026

May 6, 2026, 5:00 PM EDT - 7 weeks ago

OraSure Technologies Quarterly report: Q1 2026

OraSure Announces First Quarter 2026 Financial Results

May 6, 2026, 4:05 PM EDT - 7 weeks ago

OraSure Announces First Quarter 2026 Financial Results

OraSure Technologies Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

OraSure Technologies Proxy statement: Proxy filing

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

Apr 22, 2026, 4:10 PM EDT - 2 months ago

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

OraSure Technologies Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 2 months ago

OraSure Technologies Proxy statement: Proxy filing

OraSure Technologies Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

OraSure Technologies Proxy statement: Proxy filing

OraSure Technologies Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

OraSure Technologies Proxy statement: Proxy filing

OraSure Technologies Appoints John D. Bertrand to its Board of Directors

Apr 16, 2026, 8:10 PM EDT - 2 months ago

OraSure Technologies Appoints John D. Bertrand to its Board of Directors

OraSure Technologies Proxy statement: Proxy filing

Mar 30, 2026, 8:00 AM EDT - 3 months ago

OraSure Technologies Proxy statement: Proxy filing

OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

Mar 17, 2026, 4:52 PM EDT - 3 months ago

OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance

Mar 17, 2026, 9:15 AM EDT - 3 months ago

Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance

Exclusive: Altai Capital presses OraSure to sell and give it board seats, letter says

Mar 17, 2026, 8:02 AM EDT - 3 months ago

Exclusive: Altai Capital presses OraSure to sell and give it board seats, letter says

OraSure Technologies Proxy statement: Proxy Filing

Mar 17, 2026, 8:00 AM EDT - 3 months ago

OraSure Technologies Proxy statement: Proxy Filing

OraSure Technologies Earnings Call Transcript: Q4 2025

Feb 25, 2026, 5:00 PM EST - 4 months ago

OraSure Technologies Earnings Call Transcript: Q4 2025

OraSure Technologies Annual report: Q4 2025

Feb 25, 2026, 5:00 PM EST - 4 months ago

OraSure Technologies Annual report: Q4 2025

OraSure Technologies Earnings release: Q4 2025

Feb 25, 2026, 5:00 PM EST - 4 months ago

OraSure Technologies Earnings release: Q4 2025

OraSure to launch OraQuick HIV Self-Test in Canada

2026-02-10T13:26:24.000Z - 4 months ago

OraSure to launch OraQuick HIV Self-Test in Canada

OraSure to Launch OraQuick™ HIV Self-Test in Canada

Feb 10, 2026, 8:05 AM EST - 4 months ago

OraSure to Launch OraQuick™ HIV Self-Test in Canada

OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th

Feb 9, 2026, 4:15 PM EST - 4 months ago

OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th

OraSure confirms receipt of director nominations from Altai Capital

2026-01-15T18:05:38.000Z - 5 months ago

OraSure confirms receipt of director nominations from Altai Capital

OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital

Jan 15, 2026, 1:00 PM EST - 5 months ago

OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital

Altai Capital Management nominates two candidates to OraSure board

2026-01-15T13:45:59.000Z - 5 months ago

Altai Capital Management nominates two candidates to OraSure board

Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors

Jan 15, 2026, 8:30 AM EST - 5 months ago

Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors

OraSure Technologies Proxy statement: Proxy Filing

Jan 15, 2026, 7:00 AM EST - 5 months ago

OraSure Technologies Proxy statement: Proxy Filing

OraSure submits CT/NG molecular self-test, Colli-Pee device for FDA review

2026-01-05T13:10:09.000Z - 6 months ago

OraSure submits CT/NG molecular self-test, Colli-Pee device for FDA review

OraSure confirms Altai Capital intent to nominate two board members

2025-12-17T18:35:46.000Z - 6 months ago

OraSure confirms Altai Capital intent to nominate two board members

OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates

Dec 17, 2025, 1:23 PM EST - 6 months ago

OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates

Altai Capital announces intention to nominate two candidates for OraSure board

2025-12-17T14:25:55.000Z - 6 months ago

Altai Capital announces intention to nominate two candidates for OraSure board

Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors

Dec 17, 2025, 8:00 AM EST - 6 months ago

Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors

OraSure Technologies Proxy statement: Proxy Filing

Dec 17, 2025, 7:00 AM EST - 6 months ago

OraSure Technologies Proxy statement: Proxy Filing

OraSure Technologies Transcript: Stephens Annual Investment Conference

Nov 19, 2025, 11:00 AM EST - 7 months ago

OraSure Technologies Transcript: Stephens Annual Investment Conference

OraSure to acquire BioMedomics, expanding diagnostic portfolio

2025-11-05T22:26:30.000Z - 8 months ago

OraSure to acquire BioMedomics, expanding diagnostic portfolio

OraSure Technologies Earnings Call Transcript: Q3 2025

Nov 5, 2025, 5:00 PM EST - 8 months ago

OraSure Technologies Earnings Call Transcript: Q3 2025

OraSure Technologies Quarterly report: Q3 2025

Nov 5, 2025, 5:00 PM EST - 8 months ago

OraSure Technologies Quarterly report: Q3 2025

OraSure Technologies Earnings release: Q3 2025

Nov 5, 2025, 5:00 PM EST - 8 months ago

OraSure Technologies Earnings release: Q3 2025

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

Oct 29, 2025, 7:30 AM EDT - 8 months ago

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors

Oct 28, 2025, 4:22 PM EDT - 8 months ago

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors

OraSure Stock (OSUR) Jumps as Boardroom Drama Brews

2025-09-09T12:42:19.000Z - 10 months ago

OraSure Stock (OSUR) Jumps as Boardroom Drama Brews

C EVR

Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say

Sep 9, 2025, 6:19 AM EDT - 10 months ago

Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say

Activist warns OraSure of ‘adversarial path’ on buyout, Reuters reports

2025-08-25T16:25:20.000Z - 10 months ago

Activist warns OraSure of ‘adversarial path’ on buyout, Reuters reports

Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid

Aug 25, 2025, 12:12 PM EDT - 10 months ago

Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid

OraSure Technologies Earnings Call Transcript: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 11 months ago

OraSure Technologies Earnings Call Transcript: Q2 2025

OraSure Technologies Quarterly report: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 11 months ago

OraSure Technologies Quarterly report: Q2 2025

OraSure Technologies Earnings release: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 11 months ago

OraSure Technologies Earnings release: Q2 2025

OraSure appoints Messing as Chief Commercial Officer

2025-08-04T11:21:21.000Z - 11 months ago

OraSure appoints Messing as Chief Commercial Officer

OraSure Appoints Anne Messing as Chief Commercial Officer

Aug 4, 2025, 7:05 AM EDT - 11 months ago

OraSure Appoints Anne Messing as Chief Commercial Officer

OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th

Jul 21, 2025, 4:05 PM EDT - 1 year ago

OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th

OraSure received takeover bid from on Ron Zwanziger, Reuters reports

2025-07-14T16:15:44.000Z - 1 year ago

OraSure received takeover bid from on Ron Zwanziger, Reuters reports

OraSure bid between $3.50-$4.00 per share, Reuters says

2025-07-14T16:15:37.000Z - 1 year ago

OraSure bid between $3.50-$4.00 per share, Reuters says

OraSure up 7% to $3.33 after Reuters report of takeover bid

2025-07-14T16:15:30.000Z - 1 year ago

OraSure up 7% to $3.33 after Reuters report of takeover bid

Zwanziger offered $3.50-$4/share to buy OraSure, Reuters reports

2025-07-14T16:15:23.000Z - 1 year ago

Zwanziger offered $3.50-$4/share to buy OraSure, Reuters reports

OraSure Technologies received takeover bid from industry entrepreneur, sources say

Jul 14, 2025, 12:03 PM EDT - 1 year ago

OraSure Technologies received takeover bid from industry entrepreneur, sources say

OraSure Launches Novel Blood Collection Device for Proteomic Research

Jul 10, 2025, 7:05 AM EDT - 1 year ago

OraSure Launches Novel Blood Collection Device for Proteomic Research

OraSure Technologies Registration statement: Registration Filing

May 20, 2025, 8:00 AM EDT - 1 year ago

OraSure Technologies Registration statement: Registration Filing

OraSure Technologies Earnings Call Transcript: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

OraSure Technologies Earnings Call Transcript: Q1 2025

OraSure Technologies Quarterly report: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

OraSure Technologies Quarterly report: Q1 2025

OraSure Technologies Earnings release: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

OraSure Technologies Earnings release: Q1 2025

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

Apr 23, 2025, 4:05 PM EDT - 1 year ago

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

OraSure Technologies Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

OraSure Technologies Proxy statement: Proxy Filing

OraSure Technologies Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

OraSure Technologies Proxy statement: Proxy Filing

OraSure Announces $40 Million Stock Repurchase Program

Mar 24, 2025, 7:30 AM EDT - 1 year ago

OraSure Announces $40 Million Stock Repurchase Program

OraSure Technologies Earnings Call Transcript: Q4 2024

Feb 25, 2025, 5:00 PM EST - 1 year ago

OraSure Technologies Earnings Call Transcript: Q4 2024

OraSure Technologies Annual report: Q4 2024

Feb 25, 2025, 5:00 PM EST - 1 year ago

OraSure Technologies Annual report: Q4 2024

OraSure Technologies Earnings release: Q4 2024

Feb 25, 2025, 5:00 PM EST - 1 year ago

OraSure Technologies Earnings release: Q4 2024

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

Feb 14, 2025, 8:45 AM EST - 1 year ago

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

OraSure Technologies Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 16, 2025, 12:00 PM EST - 1 year ago

OraSure Technologies Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

OraSure Technologies Slides: FY 2025

Jan 16, 2025, 12:00 PM EST - 1 year ago

OraSure Technologies Slides: FY 2025

NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims

Jan 13, 2025, 8:00 AM EST - 1 year ago

NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims

OraSure to Present at the J.P Morgan Healthcare Conference

Jan 7, 2025, 4:05 PM EST - 1 year ago

OraSure to Present at the J.P Morgan Healthcare Conference

CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Jan 7, 2025, 8:50 AM EST - 1 year ago

CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Jan 7, 2025, 7:05 AM EST - 1 year ago

OraQuick® HIV Self-Test Now Approved for Use in Adolescents

OraSure Technologies Transcript: M&A Announcement

Dec 19, 2024, 5:00 PM EST - 1 year ago

OraSure Technologies Transcript: M&A Announcement

OraSure Technologies Press release: M&A Announcement

Dec 19, 2024, 5:00 PM EST - 1 year ago

OraSure Technologies Press release: M&A Announcement

OraSure Technologies Slides: M&A Announcement

Dec 19, 2024, 5:00 PM EST - 1 year ago

OraSure Technologies Slides: M&A Announcement

OraSure Technologies Acquires Sherlock Biosciences

Dec 19, 2024, 4:02 PM EST - 1 year ago

OraSure Technologies Acquires Sherlock Biosciences

OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test

Dec 2, 2024, 7:05 AM EST - 1 year ago

OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test

OraSure Technologies Transcript: Stephens 26th Annual Investment Conference

Nov 20, 2024, 2:00 PM EST - 1 year ago

OraSure Technologies Transcript: Stephens 26th Annual Investment Conference

OraSure to Participate in Upcoming Investor Conference

Nov 18, 2024, 4:05 PM EST - 1 year ago

OraSure to Participate in Upcoming Investor Conference

OraSure Technologies Earnings Call Transcript: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

OraSure Technologies Earnings Call Transcript: Q3 2024

OraSure Technologies Quarterly report: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

OraSure Technologies Quarterly report: Q3 2024

OraSure Technologies Earnings release: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

OraSure Technologies Earnings release: Q3 2024

OraSure Reports Q3 '24 Revenue of $39.9 Million

Nov 6, 2024, 4:05 PM EST - 1 year ago

OraSure Reports Q3 '24 Revenue of $39.9 Million

OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th

Oct 22, 2024, 4:05 PM EDT - 1 year ago

OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th

Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc

Oct 4, 2024, 4:03 PM EDT - 1 year ago

Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc

OraSure Technologies Elects Jack Kenny to the Board of Directors

Sep 9, 2024, 7:05 AM EDT - 1 year ago

OraSure Technologies Elects Jack Kenny to the Board of Directors

OraSure Technologies Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

OraSure Technologies Earnings Call Transcript: Q2 2024

OraSure Technologies Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

OraSure Technologies Quarterly report: Q2 2024

OraSure Technologies Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

OraSure Technologies Earnings release: Q2 2024

OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th

Jul 22, 2024, 4:05 PM EDT - 2 years ago

OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th

OraSure Technologies Supports National HIV Testing Day

Jun 27, 2024, 7:05 AM EDT - 2 years ago

OraSure Technologies Supports National HIV Testing Day

OraSure Technologies Earnings Call Transcript: Q1 2024

May 8, 2024, 4:45 PM EDT - 2 years ago

OraSure Technologies Earnings Call Transcript: Q1 2024

OraSure Technologies Quarterly report: Q1 2024

May 8, 2024, 4:45 PM EDT - 2 years ago

OraSure Technologies Quarterly report: Q1 2024

OraSure Technologies Earnings release: Q1 2024

May 8, 2024, 4:45 PM EDT - 2 years ago

OraSure Technologies Earnings release: Q1 2024

OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th

Apr 22, 2024, 8:00 AM EDT - 2 years ago

OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th

OraSure Technologies Proxy statement: Proxy Filing

Apr 4, 2024, 8:00 AM EDT - 2 years ago

OraSure Technologies Proxy statement: Proxy Filing

OraSure Technologies Proxy statement: Proxy Filing

Apr 3, 2024, 8:00 AM EDT - 2 years ago

OraSure Technologies Proxy statement: Proxy Filing

OraSure Technologies Proxy statement: Proxy Filing

Mar 22, 2024, 8:00 AM EDT - 2 years ago

OraSure Technologies Proxy statement: Proxy Filing

NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

Mar 21, 2024, 8:31 AM EDT - 2 years ago

NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

OraSure Technologies Earnings Call Transcript: Q4 2023

Feb 27, 2024, 5:00 PM EST - 2 years ago

OraSure Technologies Earnings Call Transcript: Q4 2023

OraSure Technologies Annual report: Q4 2023

Feb 27, 2024, 5:00 PM EST - 2 years ago

OraSure Technologies Annual report: Q4 2023

OraSure Technologies Earnings release: Q4 2023

Feb 27, 2024, 5:00 PM EST - 2 years ago

OraSure Technologies Earnings release: Q4 2023

OraSure Reports Q4 ‘23 Revenue of $75.9 Million

Feb 27, 2024, 4:05 PM EST - 2 years ago

OraSure Reports Q4 ‘23 Revenue of $75.9 Million

OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th

Feb 13, 2024, 4:05 PM EST - 2 years ago

OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th

OraSure Technologies Transcript: Investor Update

Jan 4, 2024, 9:00 AM EST - 2 years ago

OraSure Technologies Transcript: Investor Update

OraSure Technologies Press release: Investor Update

Jan 4, 2024, 9:00 AM EST - 2 years ago

OraSure Technologies Press release: Investor Update

OraSure Technologies Slides: Investor Update

Jan 4, 2024, 9:00 AM EST - 2 years ago

OraSure Technologies Slides: Investor Update

OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company

Jan 4, 2024, 7:05 AM EST - 2 years ago

OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company

OraSure Technologies Transcript: The 6th Annual Evercore ISI HealthCONx Conference

Nov 28, 2023, 3:00 PM EST - 2 years ago

OraSure Technologies Transcript: The 6th Annual Evercore ISI HealthCONx Conference

OraSure Technologies Transcript: Stephens Annual Investment Conference | NASH 2023

Nov 15, 2023, 2:00 PM EST - 2 years ago

OraSure Technologies Transcript: Stephens Annual Investment Conference | NASH 2023

OraSure to Participate in Upcoming Investor Conferences

Nov 13, 2023, 4:15 PM EST - 2 years ago

OraSure to Participate in Upcoming Investor Conferences

OraSure Technologies Earnings Call Transcript: Q3 2023

Nov 7, 2023, 5:00 PM EST - 2 years ago

OraSure Technologies Earnings Call Transcript: Q3 2023

OraSure Technologies Quarterly report: Q3 2023

Nov 7, 2023, 5:00 PM EST - 2 years ago

OraSure Technologies Quarterly report: Q3 2023

OraSure Technologies Earnings release: Q3 2023

Nov 7, 2023, 5:00 PM EST - 2 years ago

OraSure Technologies Earnings release: Q3 2023

OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th

Oct 23, 2023, 4:05 PM EDT - 2 years ago

OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th

OraSure Technologies Earnings Call Transcript: Q2 2023

Aug 3, 2023, 5:00 PM EDT - 3 years ago

OraSure Technologies Earnings Call Transcript: Q2 2023

OraSure Technologies Quarterly report: Q2 2023

Aug 3, 2023, 5:00 PM EDT - 3 years ago

OraSure Technologies Quarterly report: Q2 2023

OraSure Technologies Earnings release: Q2 2023

Aug 3, 2023, 5:00 PM EDT - 3 years ago

OraSure Technologies Earnings release: Q2 2023

OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year

Aug 3, 2023, 4:05 PM EDT - 3 years ago

OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year

OraSure Technologies Elects Robert McMahon to the Board of Directors

Jul 20, 2023, 7:05 AM EDT - 3 years ago

OraSure Technologies Elects Robert McMahon to the Board of Directors

Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

Jun 13, 2023, 4:05 PM EDT - 3 years ago

Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

OraSure Technologies Earnings Call Transcript: Q1 2023

May 10, 2023, 5:00 PM EDT - 3 years ago

OraSure Technologies Earnings Call Transcript: Q1 2023

OraSure Technologies Quarterly report: Q1 2023

May 10, 2023, 5:00 PM EDT - 3 years ago

OraSure Technologies Quarterly report: Q1 2023

OraSure Technologies Earnings release: Q1 2023

May 10, 2023, 5:00 PM EDT - 3 years ago

OraSure Technologies Earnings release: Q1 2023

OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth

May 10, 2023, 4:05 PM EDT - 3 years ago

OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth

2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET

May 3, 2023, 7:05 AM EDT - 3 years ago

2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET

OraSure Technologies Proxy statement: Proxy Filing

Apr 14, 2023, 8:00 AM EDT - 3 years ago

OraSure Technologies Proxy statement: Proxy Filing

OraSure Technologies Proxy statement: Proxy Filing

Apr 14, 2023, 8:00 AM EDT - 3 years ago

OraSure Technologies Proxy statement: Proxy Filing

OraSure Technologies Earnings Call Transcript: Q4 2022

Feb 14, 2023, 5:00 PM EST - 3 years ago

OraSure Technologies Earnings Call Transcript: Q4 2022

OraSure Technologies Annual report: Q4 2022

Feb 14, 2023, 5:00 PM EST - 3 years ago

OraSure Technologies Annual report: Q4 2022

OraSure Technologies Earnings release: Q4 2022

Feb 14, 2023, 5:00 PM EST - 3 years ago

OraSure Technologies Earnings release: Q4 2022

OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability

Feb 14, 2023, 4:05 PM EST - 3 years ago

OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability

Ageslow
Ageslow Jun. 24 at 10:20 PM
$OSUR could get Sherlock approval soon, it opens the door to a $1.5B STI testing market with the first true one-of-a-kind disposable molecular self-test — 30-min results from a swab, far faster and more user-friendly than today’s lab PCR tests. Estimated price per test: $6–15 vs lab equivalents $50–100+. This could be worth multiples of current revenue. Share price could increase 2–5x in not to distant future.
0 · Reply
DARKP00L
DARKP00L Jun. 11 at 12:16 PM
$OSUR 08:07 on Jun. 11 2026 OraSure Technologies Subsidiary DNA Genotek Receives FDA Clearance For Urine Collection Kits Use In Roche's STD Screening Kits #tradeideas
0 · Reply
MBSB
MBSB May. 28 at 6:11 PM
$OSUR i wonder if US will puchase tests for the upcoming World Cup…
0 · Reply
Estimize
Estimize May. 27 at 1:03 PM
Wall St is expecting -0.18 EPS for $OSUR Q2 [Reporting 08/11 AMC] http://www.estimize.com/intro/osur?chart=historical&metric_name=eps&utm_c
0 · Reply
Bill614
Bill614 May. 26 at 10:51 PM
$OSUR Could this be the reason Orasure has spiked over the last two trading sessions? “The OraQuick Ebola Rapid Antigen Test by OraSure Technologies is the first FDA-cleared rapid diagnostic test for Ebola. It provides presumptive detection of Ebola virus antigens in about 4-30 minutes and is used exclusively for symptomatic individuals or to screen recently deceased individuals.”
0 · Reply
insanitywolftrading
insanitywolftrading May. 21 at 10:46 PM
$OSUR $CODX both have done well but the PPE stocks are virgin territory that have not seen a major flow of volume into them yet, just trailblazers
0 · Reply
TI7812
TI7812 May. 21 at 3:03 PM
$OSUR got idea from @Hkuppy free KEDM sub. LLM AI - i forgot which one I used. lol. GROK GEMINI CLAUDE, I just don't remember. but it does look like Gemini's style. Especially like the cash per share from a R/R. GTLA
1 · Reply
deepthinker
deepthinker May. 15 at 5:04 PM
$OSUR They’ll be down to about $90 million at end of 2027. So, they’ll have spent $200 million for not much in terms of revenue growth. I can see why activists might be frustrated.
0 · Reply
RunnerSignals
RunnerSignals May. 8 at 1:29 PM
$OSUR vol 4.1x on a +4.33% move. RSI 56, room to 70. Above MA50 and MA200. MACD confirmed same session
1 · Reply
focafoca99
focafoca99 May. 6 at 8:40 PM
$OSUR released its quarter ended March 31, 2026 financial results and held a webcast.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 8:15 PM
$OSUR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.32 down -52.38% YoY • Reported revenue of $27.93M down -6.70% YoY • OraSure Technologies anticipates Q2 2026 total revenues to be in the range of $27M to $30M, reflecting the company's outlook for the upcoming quarter.
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 29 at 9:22 PM
$OSUR Share Price: $2.96 Contract Selected: Oct 16, 2026 $2.5 Calls Buy Zone: $0.51 – $0.63 Target Zone: $0.97 – $1.18 Potential Upside: 79% ROI Time to Expiration: 169 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 27 at 8:38 PM
$OSUR Current Stock Price: $3.02 Contracts to trade: $2.5 OSUR May 15 2026 Call Entry: $0.25 Exit: $0.32 ROI: 27% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
focafoca99
focafoca99 Apr. 17 at 8:01 PM
$OSUR added John Bertrand to its board, agreed with Altai Capital to pursue board declassification, and got the activist to withdraw director nominations.
0 · Reply
briefingcom
briefingcom Apr. 17 at 12:42 PM
$OSUR: OraSure appoints director and reaches agreement with activist investor https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260417044623OSUR&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
focafoca99
focafoca99 Mar. 31 at 2:07 AM
$OSUR is filing is a defense deck against Altai Capital, with management trying to control the narrative before the board fight goes any further.
0 · Reply
Estimize
Estimize Mar. 25 at 1:03 PM
Wall St is expecting -0.16 EPS for $OSUR Q1 [Reporting 05/13 AMC] http://www.estimize.com/intro/osur?chart=historical&metric_name=eps&utm_c
0 · Reply
AlertsAndNews
AlertsAndNews Mar. 24 at 2:51 AM
$OSUR Multiple insider buys here. Form 4s Kenneth J. McGrath (Chief Financial Officer) purchased 32,300 shares at an average price of $2.93 (Form 4). Carrie Eglinton Manner (Director, President & CEO) purchased 32,300 shares at an average price of $2.93 (Form 4).
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Mar. 24 at 1:25 AM
$OSUR CEO purchased 32,300 shares at $2.93 for a total of $94,597. EGLINTON MANNER CARRIE now owns 2,190,874 shares. https://ceo-buys.com
0 · Reply
Investor6
Investor6 Mar. 18 at 5:12 PM
$OSUR about the same happened with BARK, the result was the activists with Marcus Lemonis to offer $1.10 (current sp $0.81) a couple of months after their letter. So, keep an eye to any signs that a buyout proposal could occur.
1 · Reply
focafoca99
focafoca99 Mar. 17 at 9:44 PM
$OSUR is clearly responding after that Altai Capital letter
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Mar. 17 at 9:30 PM
$OSUR
0 · Reply